Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Assets Average (2020 - 2025)

Legend Biotech filings provide 6 years of Assets Average readings, the most recent being $1.7 billion for Q4 2025.

  • On a quarterly basis, Assets Average rose 1.19% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 1.19% increase, with the full-year FY2025 number at $1.7 billion, down 3.27% from a year prior.
  • Assets Average hit $1.7 billion in Q4 2025 for Legend Biotech, up from $1.7 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $308.1 billion in Q2 2021 to a low of $844.4 million in Q3 2021.
  • Median Assets Average over the past 5 years was $1.7 billion (2024), compared with a mean of $37.6 billion.
  • Biggest five-year swings in Assets Average: tumbled 99.89% in 2021 and later surged 42.65% in 2024.
  • Legend Biotech's Assets Average stood at $966.6 million in 2021, then grew by 11.92% to $1.1 billion in 2022, then skyrocketed by 70.45% to $1.8 billion in 2023, then fell by 7.64% to $1.7 billion in 2024, then increased by 1.19% to $1.7 billion in 2025.
  • The last three reported values for Assets Average were $1.7 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025) per Business Quant data.